Abstract:CD133 is a useful putative marker of cancer stem cells (CSCs) in human laryngeal tumors. Numerous studies have demonstrated that CD133(+) CSCs possess higher clonogenicity, invasiveness and tumorigenesis compared with CD133(-) cells. Recently, interest in the Warburg effect in the microenvironment of CSCs has escalated. The Warburg effect dictates that cancer cells rely on glycolysis rather than oxidative phosphorylation under aerobic conditions. In numerous cancer cells, glucose is used mainly for the glycolytic pathway. Stem cells express high levels of glycolytic enzymes and rely mostly on glycolysis to meet their energy demands. Glucose is transported through cell membranes by glucose transporters (Glut). Studies of Glut-1 expression in CSCs are limited. In the present study, we investigated the proliferation of CD133(+) Hep-2 cells and whether Glut-1 is expressed in laryngeal carcinoma CD133(+) Hep-2 cells. Real-time reverse transcription-polymerase chain reaction (RT-PCR) demonstrated that the size of the CD133 product was 213 bp. Dissociation curve analysis demonstrated only the expected peaks at 82.1 degrees C for CD133. The mean Ct of CD133 expression was 10.98. Prior to isolation, the CD133(+) fraction was 1.2% by fluorescence-activated cell sorting (FACS) analysis. Following isolation, the CD133(+) fraction was increased to 76.1%. Successive tests also demonstrated that cells grew well following isolation. The proliferation of CD133(+) and CD133(-) cells was not different during the first 3 days (P>0.05). From day 4, the proliferation capacity of CD133(+) cells in vitro was higher than that of CD133(-) cells (P<0.05). The mean Ct of Glut-1 mRNA expression was 1.78 for CD133(+) cells and 1.00 for CD133(-) cells (P<0.05). The mean Glut-1 protein values in CD133(+) and CD133(-) Hep-2 cells relative to -tubulin were 0.48 +/- 0.02 and 0.21 +/- 0.03 (g/l), respectively (P<0.05). In conclusion, CD133(+) cells demonstrated higher proliferation. Glut-1 mRNA and protein levels were higher in CD133(+) than in CD133(-) cells. Our results suggest that Glut-1 is important in the energy supply of laryngeal CD133(+) Hep-2 cells and Glut-1 may represent a potential therapeutic target for the inhibition of the proliferation of laryngeal CSCs.

Shrna Glut-1 Inhibits Cell Viability, Apoptosis and Migration of Laryngeal Carcinoma HEp-2 Cells Through Regulating Beclin-1-mediated Autophagy

Effect of GLUT1 Inhibition and Autophagy Modulation on the Growth and Migration of Laryngeal Carcinoma Stem Cells under Hypoxic and Low-Glucose Conditions

GLUT-1 Sirna Enhances Radiosensitization of Laryngeal Cancer Stem Cells Via Enhanced DNA Damage, Cell Cycle Redistribution, and Promotion of Apoptosis in Vitro and in Vivo.

Effect Of Antisense Oligodeoxynucleotides Glucose Transporter-1 On Enhancement Of Radiosensitivity Of Laryngeal Carcinoma

Apigenin Suppresses Glut-1 And P-Akt Expression To Enhance The Chemosensitivity To Cisplatin Of Laryngeal Carcinoma Hep-2 Cells: An In Vitro Study

Radiosensitizing Effects of Curcumin Alone or Combined with GLUT1 Sirna on Laryngeal Carcinoma Cells Through AMPK Pathway-Induced Autophagy

Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells.

Co-Inhibition Of Glut-1 Expression And The Pi3k/Akt Signaling Pathway To Enhance The Radiosensitivity Of Laryngeal Carcinoma Xenografts In Vivo

Expression And Significance Of Glucose Transporter-1, P-Glycoprotein, Multidrug Resistance-Associated Protein And Glutathione S-Transferase-Pi In Laryngeal Carcinoma

Effect of Combination of Curcumin and GLUT-1 AS-ODN on Radiosensitivity of Laryngeal Carcinoma Through Regulating Autophagy

Expression and Significance of Hypoxia-Inducible Factor-1Α and Glucose Transporter-1 in Laryngeal Carcinoma.

Inhibition of Cell Proliferation and Glucose Uptake in Human Laryngeal Carcinoma Cells by Antisense Oligonucleotides Against Glucose Transporter‐1

Effect on the Expression of MMP-2, MT-MMP in Laryngeal Carcinoma Hep-2 Cell Line by Antisense Glucose Transporter-1.

Inhibition of GLUT-1 Expression and the PI3K/Akt Pathway to Enhance the Chemosensitivity of Laryngeal Carcinoma Cells in Vitro

Role of GLUT-1 in the Upregulation of PD-L1 Expression after Radiotherapy and Association of PD-L1 with Favourable Overall Survival in Hypopharyngeal Cancer

Knockdown of Beclin-1 Impairs Epithelial-Mesenchymal Transition of Colon Cancer Cells.

Proliferation and Migration Inhibition of Adenoid Cystic Carcinoma Cells Through Autophagy Suppression Via GLUT1 Knockdown

Effect of Glut‐1 and HIF‐1α double knockout by CRISPR/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K/Akt/mTOR pathway

Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathwayResearch in context

Targeting Glutaminase 1 Attenuates Stemness Properties in Hepatocellular Carcinoma by Increasing Reactive Oxygen Species and Suppressing Wnt/beta-catenin Pathway

Effects of Suppressing Glucose Transporter-1 by an Antisense Oligodeoxynucleotide on the Growth of Human Hepatocellular Carcinoma Cells